Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

PMID:
31300547
2.

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.

Balloy G, Pelletier J, Suchet L, Lebrun C, Cohen M, Vermersch P, Zephir H, Duhin E, Gout O, Deschamps R, Le Page E, Edan G, Labauge P, Carra-Dallieres C, Rumbach L, Berger E, Lejeune P, Devos P, N'Kendjuo JB, Coustans M, Auffray-Calvier E, Daumas-Duport B, Michel L, Lefrere F, Laplaud DA, Brosset C, Derkinderen P, de Seze J, Wiertlewski S; Société Francophone de la Sclérose en Plaques.

J Neurol. 2018 Oct;265(10):2251-2259. doi: 10.1007/s00415-018-8984-7. Epub 2018 Jul 27.

PMID:
30054790
3.

Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.

Ducloyer JB, Michel L, Wiertlewski S, Lebranchu P.

Eur J Ophthalmol. 2019 Mar;29(2):257-261. doi: 10.1177/1120672118784797. Epub 2018 Jul 4.

PMID:
29972029
4.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
5.

An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.

Nicol B, Salou M, Vogel I, Garcia A, Dugast E, Morille J, Kilens S, Charpentier E, Donnart A, Nedellec S, Jacq-Foucher M, Le Frère F, Wiertlewski S, Bourreille A, Brouard S, Michel L, David L, Gourraud PA, Degauque N, Nicot AB, Berthelot L, Laplaud DA.

J Autoimmun. 2018 Mar;88:61-74. doi: 10.1016/j.jaut.2017.10.005. Epub 2017 Oct 18.

6.

[First case report of Gordonia aichiensis bacteremia].

Thomas E, Lejeune F, Caillon J, Wiertlewski S, Crémet L.

Med Mal Infect. 2017 Nov;47(7):508-509. doi: 10.1016/j.medmal.2017.07.009. Epub 2017 Sep 21. French. No abstract available.

PMID:
28943173
7.

Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? YES.

Wiertlewski S.

Rev Neurol (Paris). 2017 Dec;173(10):610-613. doi: 10.1016/j.neurol.2017.06.004. Epub 2017 Jul 29. No abstract available.

PMID:
28760447
8.

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.

Pignolet B, Schwab N, Schneider-Hohendorf T, Bucciarelli F, Biotti D, Averseng-Peaureaux D, Outteryck O, Ongagna JC, de Sèze J, Brochet B, Ouallet JC, Debouverie M, Pittion S, Defer G, Derache N, Hautecoeur P, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Berger E, Pelletier J, Rico A, Zéphir H, Laplaud D, Wiertlewski S, Camu W, Thouvenot E, Casez O, Moreau T, Fromont A, Vukusic S, Papeix C, Vermersch P, Comabella M, Lebrun-Frenay C, Wiendl H, Brassat D; BIONAT, SFSEP, and BEST-MS networks.

Neurology. 2016 Dec 6;87(23):2491-2494. Epub 2016 Nov 4. No abstract available.

PMID:
27815407
9.

Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.

Salou M, Nicol B, Garcia A, Baron D, Michel L, Elong-Ngono A, Hulin P, Nedellec S, Jacq-Foucher M, Le Frère F, Jousset N, Bourreille A, Wiertlewski S, Soulillou JP, Brouard S, Nicot AB, Degauque N, Laplaud DA.

Clin Immunol. 2016 May;166-167:1-11. doi: 10.1016/j.clim.2016.03.014. Epub 2016 Apr 2.

PMID:
27050759
10.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

11.

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability.

Zéphir H, Bernard-Valnet R, Lebrun C, Outteryck O, Audoin B, Bourre B, Pittion S, Wiertlewski S, Ouallet JC, Neau JP, Ciron J, Clavelou P, Marignier R, Brassat D.

J Neurol. 2015 Oct;262(10):2329-35. doi: 10.1007/s00415-015-7852-y. Epub 2015 Jul 21.

PMID:
26194198
12.

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Le Page E, Veillard D, Laplaud DA, Hamonic S, Wardi R, Lebrun C, Zagnoli F, Wiertlewski S, Deburghgraeve V, Coustans M, Edan G; COPOUSEP investigators; West Network for Excellence in Neuroscience.

Lancet. 2015 Sep 5;386(9997):974-81. doi: 10.1016/S0140-6736(15)61137-0. Epub 2015 Jun 28. Erratum in: Lancet. 2016 Jan 23;387(10016):340.

13.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Defer GL, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2015 Feb;138(Pt 2):284-92. doi: 10.1093/brain/awu353. Epub 2014 Dec 19.

PMID:
25527826
14.

Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.

Michel L, Chesneau M, Manceau P, Genty A, Garcia A, Salou M, Elong Ngono A, Pallier A, Jacq-Foucher M, Lefrère F, Wiertlewski S, Soulillou JP, Degauque N, Laplaud DA, Brouard S.

Clin Immunol. 2014 Dec;155(2):198-208. doi: 10.1016/j.clim.2014.09.011. Epub 2014 Sep 28.

PMID:
25267439
15.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
16.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP.

Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12.

PMID:
23895407
17.

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.

Michel L, Vukusic S, De Seze J, Ducray F, Ongagna JC, Lefrère F, Jacq-Foucher M, Confavreux C, Wiertlewski S, Laplaud DA.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):279-83. doi: 10.1136/jnnp-2013-305298. Epub 2013 May 23.

PMID:
23704316
18.

Increased risk of multiple sclerosis relapse after in vitro fertilisation.

Michel L, Foucher Y, Vukusic S, Confavreux C, de Sèze J, Brassat D, Clanet M, Clavelou P, Ouallet JC, Brochet B, Pelletier J, Labauge P, Lebrun C, Lepage E, Le Frere F, Jacq-Foucher M, Barriere P, Wiertlewski S, Laplaud DA; Club Francophone de la Sclérose En Plaques (CFSEP).

J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):796-802. doi: 10.1136/jnnp-2012-302235. Epub 2012 Jun 11.

PMID:
22693287
19.

Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients.

Kerbrat A, Le Page E, Leray E, Anani T, Coustans M, Desormeaux C, Guiziou C, Kassiotis P, Lallement F, Laplaud D, Diraison P, Rouhart F, Sartori E, Wardi R, Wiertlewski S, Edan G.

J Neurol Sci. 2011 Sep 15;308(1-2):98-102. doi: 10.1016/j.jns.2011.05.043. Epub 2011 Jun 12.

PMID:
21665227
20.

Multiple sclerosis and access to healthcare in the Pays de la Loire region: preliminary study based on 130 self-applied double questionnaires.

Le Fort M, Wiertlewski S, Bernard I, Bernier C, Bonnemain B, Moreau C, Nicolas-Chouet C, Pavillon T, Tanguy E, Villard A, Bertout P, Bodic P, Desjobert S, Kieny P, Lejeune P, Lombrail P; RESEP-Loire.

Ann Phys Rehabil Med. 2011 May;54(3):156-71. doi: 10.1016/j.rehab.2011.02.005. Epub 2011 Apr 6. English, French.

21.

Atypical neurologic complications in patients with primary Sjögren's syndrome: report of 4 cases.

Michel L, Toulgoat F, Desal H, Laplaud DA, Magot A, Hamidou M, Wiertlewski S.

Semin Arthritis Rheum. 2011 Feb;40(4):338-42. doi: 10.1016/j.semarthrit.2010.06.005. Epub 2010 Aug 10.

PMID:
20701954
22.

T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis.

Bahbouhi B, Pettré S, Berthelot L, Garcia A, Elong Ngono A, Degauque N, Michel L, Wiertlewski S, Lefrère F, Meyniel C, Delcroix C, Brouard S, Laplaud DA, Soulillou JP.

Brain. 2010 Jun;133(Pt 6):1622-36. doi: 10.1093/brain/awq074. Epub 2010 Apr 30.

PMID:
20435630
23.

[Optic neuritis].

Meyniel C, Wiertlewski S.

Rev Med Interne. 2010 Jul;31(7):481-5. doi: 10.1016/j.revmed.2009.03.372. French.

PMID:
20434241
24.

Neuromyelitis optica in France: a multicenter study of 125 patients.

Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, Gout O, Rodriguez D, Wiertlewski S, Laplaud D, Borgel F, Tourniaire P, Grimaud J, Brochet B, Vermersch P, Confavreux C, de Seze J.

Neurology. 2010 Mar 2;74(9):736-42. doi: 10.1212/WNL.0b013e3181d31e35.

PMID:
20194912
25.

Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.

Berthelot L, Miqueu P, Pettré S, Guillet M, Moynard J, Wiertlewski S, Lefrère F, Brouard S, Soulillou JP, Laplaud DA.

Clin Immunol. 2010 Apr;135(1):33-42. doi: 10.1016/j.clim.2009.12.006. Epub 2010 Feb 8.

PMID:
20116333
26.

Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.

Bahbouhi B, Berthelot L, Pettré S, Michel L, Wiertlewski S, Weksler B, Romero IA, Miller F, Couraud PO, Brouard S, Laplaud DA, Soulillou JP.

J Leukoc Biol. 2009 Nov;86(5):1049-63. doi: 10.1189/jlb.1008666. Epub 2009 Aug 20.

PMID:
19696154
27.

Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis.

Michel L, Berthelot L, Pettré S, Wiertlewski S, Lefrère F, Braudeau C, Brouard S, Soulillou JP, Laplaud DA.

J Clin Invest. 2008 Oct;118(10):3411-9. doi: 10.1172/JCI35365.

28.

Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.

Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP.

Eur J Immunol. 2008 Jul;38(7):1889-99. doi: 10.1002/eji.200838023.

29.

Acute fulminant demyelinating disease: a descriptive study of 60 patients.

de Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, Wiertlewski S, Pittion S, Laplaud D, Le Page E, Deschamps R, Cabre P, Pelletier J, Malikova I, Clavelou P, Jaillon V, Defer G, Labauge P, Gout O, Boulay C, Edan G, Vermersch P.

Arch Neurol. 2007 Oct;64(10):1426-32.

PMID:
17923626
30.

[Increased risk of relapse in multiple sclerosis patients after ovarian stimulation for in vitro fertilization].

Laplaud DA, Lefrère F, Leray E, Barrière P, Wiertlewski S.

Gynecol Obstet Fertil. 2007 Oct;35(10):1047-50. Epub 2007 Oct 3. French.

PMID:
17916439
31.

[Presentation of cerebral toxocariasis with mental confusion in an adult: case report and review of the literature].

Maiga Y, Wiertlewski S, Desal H, Marjolet M, Damier P.

Bull Soc Pathol Exot. 2007 May;100(2):101-4. Review. French.

PMID:
17727029
32.

[Idiopathic acute transverse myelitis: application of new diagnosis criteria to 17 patients].

Lanctin C, Wiertlewski S, Moreau C, Verny C, Derkinderen P, Damier P, Dubas F.

Rev Neurol (Paris). 2006 Oct;162(10):980-9. French.

PMID:
17028566
33.

Increase in multiple sclerosis relapse rate following in vitro fertilization.

Laplaud DA, Leray E, Barrière P, Wiertlewski S, Moreau T.

Neurology. 2006 Apr 25;66(8):1280-1. No abstract available.

PMID:
16636258
34.

Idiopathic acute transverse myelitis: application of the recent diagnostic criteria.

de Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, Pelletier J, Gout O, Clerc C, Moreau C, Defer G, Edan G, Dubas F, Vermersch P.

Neurology. 2005 Dec 27;65(12):1950-3.

PMID:
16380618
35.

[Dural arteriovenous fistula. A rare cause of treatable dementia].

Magot A, Desal H, Wiertlewski S, Houdart E, Vercelletto M, Al Hammad Ibrahim M, Guillon B.

Rev Neurol (Paris). 2004 Apr;160(4 Pt 1):425-33. Review. French.

PMID:
15103267
36.

Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.

Laplaud DA, Ruiz C, Wiertlewski S, Brouard S, Berthelot L, Guillet M, Melchior B, Degauque N, Edan G, Brachet P, Damier P, Soulillou JP.

Brain. 2004 May;127(Pt 5):981-95. Epub 2004 Feb 25.

PMID:
14985265
37.

Worsening of neurologic symptoms after epidural anesthesia for labor in a Guillain-Barré patient.

Wiertlewski S, Magot A, Drapier S, Malinovsky JM, Péréon Y.

Anesth Analg. 2004 Mar;98(3):825-7, table of contents.

PMID:
14980945
38.

Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection.

Melchior B, Nerrière-Daguin V, Laplaud DA, Rémy S, Wiertlewski S, Neveu I, Naveilhan P, Meakin SO, Brachet P.

Exp Neurol. 2003 Oct;183(2):367-78.

PMID:
14552878
39.

[Multinodular presentation of multiple sclerosis].

Wiertlewski S, Auffray-Calvier E, Guillon B.

Rev Neurol (Paris). 2003 May;159(5 Pt 1):590-2. French. No abstract available.

PMID:
12773908
40.

[Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis].

Vercelletto M, Belliard S, Wiertlewski S, Venisse T, Magne C, Duyckaerts C, Damier P.

Rev Neurol (Paris). 2003 May;159(5 Pt 1):529-42. Review. French.

PMID:
12773898
41.

[Ptosis and mastication disorders revealing concurrent myasthenia gravis and chronic polyradiculoneuritis].

Magot A, Wiertlewski S, Boutoleau C, Guiheneuc P, Fève JR, Damier P.

Rev Neurol (Paris). 2002 Jul;158(6-7):741-3. French.

PMID:
12486907
42.

[Acute confusion and cerebral infarcts].

Wiertlewski S, Guillon B.

Rev Neurol (Paris). 2002 Apr;158(4):486-8. French. No abstract available.

PMID:
11984494
43.

[Late cerebrovascular complications of cardiac transplantation].

Guillon B, Wiertlewski S, Trochu JN, Desal H, Treilhaud M, Michaud JL, Bouhour JB, Fève JR.

Rev Neurol (Paris). 2000 Mar;156(3):264-9. French.

PMID:
10740097

Supplemental Content

Loading ...
Support Center